Your browser doesn't support javascript.
loading
British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.
Rutter, Matthew D; East, James; Rees, Colin J; Cripps, Neil; Docherty, James; Dolwani, Sunil; Kaye, Philip V; Monahan, Kevin J; Novelli, Marco R; Plumb, Andrew; Saunders, Brian P; Thomas-Gibson, Siwan; Tolan, Damian J M; Whyte, Sophie; Bonnington, Stewart; Scope, Alison; Wong, Ruth; Hibbert, Barbara; Marsh, John; Moores, Billie; Cross, Amanda; Sharp, Linda.
Afiliación
  • Rutter MD; Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, UK matt.rutter@nth.nhs.uk.
  • East J; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Rees CJ; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.
  • Cripps N; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Docherty J; Gastroenterology, South Tyneside NHS Foundation Trust, South Shields, UK.
  • Dolwani S; Western Sussex Hospitals NHS Foundation Trust, Chichester, UK.
  • Kaye PV; Colorectal surgery, Raigmore Hospital, Inverness, UK.
  • Monahan KJ; Gastroenterology, Cardiff and Vale NHS Trust, Cardiff, UK.
  • Novelli MR; Histopathology, Nottingham University Hospitals, Nottingham, UK.
  • Plumb A; Family History of Bowel Cancer Clinic, West Middlesex University Hospital, London, UK.
  • Saunders BP; Imperial College, London, UK.
  • Thomas-Gibson S; Histopathology, University College London, London, UK.
  • Tolan DJM; Centre for Medical Imaging, UCL, London, UK.
  • Whyte S; Endoscopy, St Marks Hospital, London, UK.
  • Bonnington S; Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.
  • Scope A; Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Wong R; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • Hibbert B; Gastroenterology, University Hospital of Hartlepool, Hartlepool, UK.
  • Marsh J; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • Moores B; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • Cross A; London, UK.
  • Sharp L; London, UK.
Gut ; 69(2): 201-223, 2020 02.
Article en En | MEDLINE | ID: mdl-31776230
ABSTRACT
These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to addressWhich patients should commence surveillance post-polypectomy and post-cancer resection?What is the appropriate surveillance interval?When can surveillance be stopped? two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG's guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant.two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise eithertwo or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps This cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Pólipos del Colon / Vigilancia de la Población Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Gut Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Pólipos del Colon / Vigilancia de la Población Tipo de estudio: Diagnostic_studies / Guideline / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Gut Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido